April 21, 2021 – The U.S. FDA has approved an expanded indication for Diovan® (valsartan) oral tablets,
manufactured by Novartis, to treat hypertension in patients who are at least one year of age
April 19, 2021 – The U.S. FDA has approved an expanded indication for Ragwitek® (short ragweed pollen allergen extract) sublingual tablets to treat short ragweed pollen-induced allergic
April 16, 2021 – The U.S. FDA has approved Nextstellis® (3mg drospirenone/14.2mg estetrol
tablets), manufactured by Mayne Pharma, for use by females of reproductive potential
April 16, 2021 – The U.S. FDA has approved a new indication for Opdivo® (nivolumab), manufactured by Bristol Myers Squibb. The drug is now indicated for use in combination with fluoropyrimidine
April 13, 2021 – The U.S. FDA has given accelerated approval to Trodelvy® (sacituzumab govitecan-hziy), manufactured by Gilead, for a new indication to treat locally advanced or
April 13, 2021 - Global Reach Health, committed to giving back to the community and beyond, hosted a donation drive this past week, for necessary supplies needed in Guatemala.